Ocular Therapeutix (OCUL) Short Interest Ratio & Short Volume → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free OCUL Stock Alerts $6.17 -0.10 (-1.59%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ocular Therapeutix Short Interest DataCurrent Short Volume21,080,000 sharesPrevious Short Volume14,650,000 sharesChange Vs. Previous Month+43.89%Dollar Volume Sold Short$99.92 millionShort Interest Ratio / Days to Cover7.8Last Record DateApril 30, 2024Outstanding Shares154,890,000 sharesPercentage of Shares Shorted13.61%Today's Trading Volume1,186,468 sharesAverage Trading Volume3,562,918 sharesToday's Volume Vs. Average33% Short Selling Ocular Therapeutix ? Sign up to receive the latest short interest report for Ocular Therapeutix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOCUL Short Interest Over TimeOCUL Days to Cover Over TimeOCUL Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Ocular Therapeutix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202421,080,000 shares $99.92 million +43.9%N/A7.8 $4.74 4/15/202414,650,000 shares $114.27 million +24.1%N/A6.3 $7.80 3/31/202411,810,000 shares $107.47 million +28.9%N/A5.8 $9.10 3/15/20249,160,000 shares $86.65 million +93.3%N/A4.5 $9.46 2/29/20244,740,000 shares $47.68 million +19.4%N/A2.4 $10.06 2/15/20243,970,000 shares $27.23 million +0.3%N/A2.3 $6.86 Get the Latest News and Ratings for OCUL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,960,000 shares $19.25 million +18.2%N/A2.9 $4.86 1/15/20243,350,000 shares $14.71 million -23.5%N/A2.5 $4.39 12/31/20234,380,000 shares $19.53 million -3.5%N/A3.6 $4.46 12/15/20234,540,000 shares $17.84 million -14.0%N/A3.9 $3.93 11/30/20235,280,000 shares $13.09 million -9.1%7.0%5.9 $2.48 11/15/20235,810,000 shares $13.07 million +22.1%7.7%7.5 $2.25 10/31/20234,760,000 shares $13.57 million +9.4%6.3%6 $2.85 10/15/20234,350,000 shares $10.83 million +6.4%5.8%6.2 $2.49 9/30/20234,090,000 shares $12.84 million -1.7%5.4%5.7 $3.14 9/15/20234,160,000 shares $14.48 million +1.2%5.5%5.2 $3.48 8/31/20234,110,000 shares $15.54 million -16.5%5.5%3.8 $3.78 8/15/20234,920,000 shares $22.19 million -20.3%6.5%4.1 $4.51 7/31/20236,170,000 shares $28.01 million -8.2%N/A5.1 $4.54 7/15/20236,720,000 shares $32.05 million -1.2%N/A5.2 $4.77 6/30/20236,800,000 shares $35.09 million +4.3%N/A5.4 $5.16 6/15/20236,520,000 shares $32.40 million -2.0%N/A5.2 $4.97 5/31/20236,650,000 shares $42.56 million +20.3%N/A6.8 $6.40 5/15/20235,530,000 shares $35.00 million +14.3%N/A5.4 $6.33 4/30/20234,840,000 shares $30.01 million +13.4%N/A3.1 $6.20 4/15/20234,270,000 shares $22.46 million -7.2%N/A2.8 $5.26 3/31/20234,600,000 shares $24.24 million +2.7%N/A3.2 $5.27 3/15/20234,480,000 shares $22.85 million +12.6%N/A3.1 $5.10 2/28/20233,980,000 shares $24.04 million +27.2%N/A2.9 $6.04 2/15/20233,130,000 shares $19.06 million +6.5%4.1%2.4 $6.09 1/31/20232,940,000 shares $11.50 million +4.3%3.9%4.6 $3.91 1/15/20232,820,000 shares $11.28 million -5.1%N/A4.3 $4.00 12/30/20222,970,000 shares $8.35 million -2.3%N/A4.5 $2.81 12/15/20223,040,000 shares $8.42 million +4.1%N/A3.5 $2.77 11/30/20222,920,000 shares $8.67 million -0.3%N/A3.5 $2.97 11/15/20222,930,000 shares $9.43 million -12.0%N/A3.4 $3.22 10/31/20223,330,000 shares $12.02 million +2.2%N/A3.8 $3.61 10/15/20223,260,000 shares $13.43 million +9.4%N/A3.9 $4.12 9/30/20222,980,000 shares $12.37 million +2.4%N/A3.8 $4.15 9/15/20222,910,000 shares $18.07 million -12.1%N/A5.4 $6.21Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. OCUL Short Interest - Frequently Asked Questions What is Ocular Therapeutix's current short interest? Short interest is the volume of Ocular Therapeutix shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 21,080,000 shares of OCUL short. Learn More on Ocular Therapeutix's current short interest. What is a good short interest ratio for Ocular Therapeutix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUL shares currently have a short interest ratio of 8.0. Learn More on Ocular Therapeutix's short interest ratio. Is Ocular Therapeutix's short interest increasing or decreasing? Ocular Therapeutix saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 21,080,000 shares, an increase of 43.9% from the previous total of 14,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocular Therapeutix's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Ocular Therapeutix: Arcutis Biotherapeutics, Inc. (18.74%), Liquidia Co. (10.62%), Centessa Pharmaceuticals plc (2.99%), OPKO Health, Inc. (26.42%), Bicycle Therapeutics plc (6.52%), Tyra Biosciences, Inc. (11.01%), 89bio, Inc. (10.93%), Immunome, Inc. (4.42%), ABIVAX Société Anonyme (0.12%), ARS Pharmaceuticals, Inc. (15.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Ocular Therapeutix stock? Short selling OCUL is an investing strategy that aims to generate trading profit from Ocular Therapeutix as its price is falling. OCUL shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocular Therapeutix? A short squeeze for Ocular Therapeutix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUL, which in turn drives the price of the stock up even further. How often is Ocular Therapeutix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Arcutis Biotherapeutics Short Interest Data Liquidia Short Interest Data Centessa Pharmaceuticals Short Interest Data OPKO Health Short Interest Data Bicycle Therapeutics Short Interest Data Tyra Biosciences Short Interest Data 89bio Short Interest Data Immunome Short Interest Data ABIVAX Société Anonyme Short Interest Data ARS Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media41 banks launch ‘crypto dollar’Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMost important medical advance in 100 yearsThe Oxford Club